Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Verona Pharma (VRNA) has a market cap of $7.78 billion USD. According to our data, Verona Pharma is ranked No.1929 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $7.78 B |
104.80%
|
| Dec 31, 2024 | $3.80 B |
133.60%
|
| Dec 29, 2023 | $1.63 B |
-23.92%
|
| Dec 30, 2022 | $2.14 B |
288.84%
|
| Dec 31, 2021 | $0.55 B |
-4.00%
|
| Dec 31, 2020 | $0.57 B |
21.74%
|
| Dec 31, 2019 | $0.47 B |
-40.41%
|
| Dec 31, 2018 | $0.79 B |
-18.71%
|
| Dec 29, 2017 | $0.97 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
| Market Cap | = | VRNA Stock Price | * | VRNA Shares Outstanding |
| = | $58.47 | * | 85.02 M | |
| = | $7.78 B |